This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance Of U.S. Patent For Treatment Of Skin Ulcers With Microcyn(R) Technology

PETALUMA, Calif., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective drugs, devices and nutritional products, today announced the issuance of new U.S. patent for the use of Microcyn® Technology in the treatment of skin ulcers. In this application, Microcyn Technology can be delivered to skin ulcers via washing, irrigation and soaking or through application of a wound dressing saturated in the Microcyn Technology. According to claims allowed by the patent examiner, the application of the Microcyn Technology via these methods will:

  • Reduce the microbial load of an infected diabetic foot ulcer;
  • Decrease the recurrence rate of an infected diabetic foot ulcer;
  • Decrease the likelihood of dehiscence of an infected diabetic foot ulcer;
  • Decrease the likelihood of amputation resulting from an infected diabetic foot ulcer;
  • Decrease the likelihood of systemic inflammatory response syndrome from an infected diabetic foot ulcer;
  • Decrease the likelihood of sepsis resulting from an infected diabetic foot ulcer.

Jim Schutz, CEO of Oculus said: "Healing open skin ulcers is a significant challenge for healthcare professionals around the world.  Just in the United States, more than six million Americans each year suffer chronic wounds including arterial, diabetic, pressure and venous ulcers. This latest issued patent is perfectly timed with changes to healthcare rules under the Affordable Care Act, which penalize healthcare institutions for failure to use best-in-class, cost-effective products, such as Microcyn. We are increasing our efforts to convey that compelling message as broadly as possible throughout the U.S. healthcare system."  

The latest-issued patent joins an intellectual property estate (either owned or licensed to Oculus) that now includes 33 issued patents (seven in the U.S. and two in the E.U.) as well 113 pending applications directed to chemical compositions, apparatuses, methods of manufacturing and therapeutic uses.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs